Entellus Medical Inc. priced an offering of 2,353,530 shares at $17 apiece to raise funds for working capital purposes, including the repayment of its credit facility.

The company also granted underwriters a 30-day option to purchase up to an additional 529,500 of the shares offered.

The offering is expected to close Jan. 31.

Meanwhile, certain Entellus shareholders also plan to sell 1,176,470 shares of the company at the same price.

BofA Merrill Lynch and Piper Jaffray & Co. are acting as joint book-running managers for the offering. William Blair is acting as co-manager.